吕 晗1a,刘 洋1b,2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2,孙 婧1a,赵 磊1a,李梦伊1b,2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2,张 鹏1b,2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2,杨正汉1a,王振常1a,张忠涛1b,2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2
摘要: 目的 探讨垂体磁共振(MR)检查在减重与代谢手术病人中常规开展的必要性及其应用条件。方法 回顾性分析2016年1月1日至2019年12月31日首都医科大学附属北京友谊医院普通外科中心减重与代谢外科收治的行垂体MR检查的312例代谢综合征病人的临床资料。将MR检查结果根据影响临床决策的程度分为Ⅰ~Ⅴ类。统计垂体MR检查的整体阳性率、检查目的相关阳性率、影响临床决策阳性率。结果 垂体MR检查结果中Ⅰ类263例(84.3%),Ⅱ类15例(4.8%),Ⅲ类21例(6.7%),Ⅳ类3例(1.0%),Ⅴ类10例(3.2%)。整体阳性率为15.7%(49/312);检查目的相关阳性率为7.7%(24/312);影响临床决策阳性率为0.6%(2/312),包括垂体大腺瘤1例、脑肿瘤1例。 结论 对于减重与代谢手术病人,因垂体MR平扫检查阳性率低,为临床提供价值较小,极少影响临床决策,不推荐常规开展;对于临床怀疑垂体病变所致继发性肥胖或病人,推荐垂体MR增强检查;对于伴中枢神经系统症状病人,推荐颅脑MR增强检查。